Shares of Apricus tank after FDA declines to OK erectile dysfunction cream

(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.

from Reuters: Health News http://ift.tt/2EHJqBx February 16, 2018 at 06:00AM